Warwick Tong
Net worth: 228 755 $ as of 2026-05-30
Net worth: 228 755 $ as of 2026-05-30
Warwick Tong is currently Chairman at Biomedical Research Australia.
Other current roles include Independent Non-Executive Director at Amplia Therapeutics Ltd. starting in 2026, Director at Amplia Therapeutics Uk Ltd., Director at ACULEUS THERAPEUTICS PTY LTD, Director at Pacalis Therapeutics Pty Ltd., Member-Governance Board at Arc Centre For Excellence In Convergent Bio-Nano Science & Tec, and Member at Maurice Wilkins Centre.
Former positions include Chief Executive Officer & Director at Oncology One Pty Ltd. from 2011 to 2018, Chairman at CTxONE from 2018 to 2020, Chairman at Biomedical Research Victoria from 2018 to 2019, Medical Director at GlaxoSmithKline NZ Ltd. from 1993 to 1997, Medical Director at Glaxo Wellcome Manufacturing Pte Ltd., Senior Vice President-Development at Surface Logix LLC from 2010 to 2012, and Vice President-World Wide Development at GSK Plc.
Education includes graduation from Victoria University of Wellington.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-09-05 | 2,355,140 ( 0.46% ) | 228 755 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Director/Board Member | 2026-06-29 |
Biomedical Research Australia | Chairman | - |
Arc Centre For Excellence In Convergent Bio-Nano Science & Tec | Director/Board Member | - |
Amplia Therapeutics Uk Ltd. | Director/Board Member | - |
Maurice Wilkins Centre | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
CTxONE | Chief Executive Officer | - |
Biomedical Research Victoria | Chairman | 2019-11-30 |
Oncology One Pty Ltd.
Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Chief Executive Officer | 2018-04-29 |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Corporate Officer/Principal | 2012-10-02 |
| ░░░░░░░░░░░░░░░ ░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Health Technology |
Oncology One Pty Ltd.
Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Victoria University of Wellington
Victoria University of Wellington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithkline NZ Ltd.
GlaxoSmithkline NZ Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Glaxo Wellcome Manufacturing Pte Ltd.
Glaxo Wellcome Manufacturing Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Amplia Therapeutics Ltd.
Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
CTxONE | |
Biomedical Research Australia | |
Arc Centre For Excellence In Convergent Bio-Nano Science & Tec | |
Maurice Wilkins Centre | |
Biomedical Research Victoria | |
Amplia Therapeutics Uk Ltd. |
Select your edition
All financial news and data tailored to specific country editions